The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Thousands of lawsuits make similar allegations that discontinued heartburn drug Zantac caused cancer. REUTERS. Attorneys for Valadez had asked the jury to award $640 million for her suffering.

The lawsuits over the drug say its active ingredient, ranitidine, under some conditions turns into a cancer-causing substance called NDMA. Attorneys for Valadez had asked the jury to award $640 ...

The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above ...

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...

“Because if Zantac caused my cancer, I don’t think it’s right that they get away with it.” In 2020, the FDA recalled ranitidine, including Zantac and its generics, after a lab found ...

Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims The executive, a medical doctor who oversaw drug safety for decades at drugmaker GSK, repeatedly ...

The jury found that Valadez proved that she had taken Zantac, but not that it was a cause of her cancer. First approved in 1983, Zantac became the world's best selling medicine in 1988 and one of ...